NCT04610827View on ClinicalTrials.gov

Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder

PHASE4TerminatedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

June 29, 2021

Study Completion Date

June 29, 2021

Conditions

Sleep DisorderRestless Legs SyndromePeriodic Limb Movement Sleep DisorderIron-deficiency

Interventions

DRUG

Ferrous sulfate

Guideline-recommended 3 mg/kg/day dosing

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT04610827 - Oral Iron Frequency for Childhood Restless Leg Syndrome/Periodic Limb Movement Disorder | Biotech Hunter | Biotech Hunter